PHYSIOLOGICAL AND PATHOLOGICAL IMPACT OF HEPATITIS B AND C, PUBLIC HEALTH STRATEGIES FOR PREVENTION AND CONTROL
Main Article Content
Keywords
Hepatitis B, Hepatitis C, Liver Function, Cirrhosis, Public Health, Pakistan
Abstract
Objectives: The goal of this study is to analyze the physiological and pathological impacts of hepatitis B and C on liver and to measure the effectiveness of the health-related prevention and control programs in Pakistan.
Materials and Methods: This was a cross-sectional and prospective investigation of 200 patients with chronic hepatitis B or C in Karachi, Pakistan, who were evaluated with liver function tests (ALT, AST), abdominal ultrasonography, and serological markers. Demographic factors, health behavior, and medical history data were also captured.
Results: Both hepatitis B and C patients were shown to have increased ALT and AST, with hepatitis C presenting higher results for both tests. In contrast, 40% of hepatitis C patients were shown to have cirrhosis via ultrasound examination compared to 20% of hepatitis B patients. A large proportion of the participants came from low household incomes, and many did not know their infection status.
Conclusion: Hepatitis B and C are medically categorized as Liver disorders with Hepatitis C being more dangerous to the liver than Hepatitis B. As a result, early diagnosis and intervention were critical for improving health status.
References
2- World Health Organization, 2020. Training modules on Hepatitis B and C screening, diagnosis and treatment.
3- Lu, J., Xing, H., Wang, C., Tang, M., Wu, C., Ye, F., Yin, L., Yang, Y., Tan, W. and Shen, L., 2023. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduction and Targeted Therapy, 8(1), p.458.
4- Zhao, F., Xie, X., Tan, X., Yu, H., Tian, M., Lv, H., Qin, C., Qi, J. and Zhu, Q., 2021. The functions of hepatitis B virus encoding proteins: viral persistence and liver pathogenesis. Frontiers in immunology, 12, p.691766.
5- You, H., Wang, X., Ma, L., Zhang, F., Zhang, H., Wang, Y., Pan, X., Zheng, K., Kong, F. and Tang, R., 2023. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Communication and Signaling, 21(1), p.70.
6- El Sayed, S.M., 2023. Al-hijamah (prophetic wet cupping therapy) is a novel adjuvant treatment for viral hepatitis that excretes viral particles and excess ferritin percutaneously, synergizes pharmacotherapy, enhances antiviral immunity and helps better HCC prevention and treatment: a novel evidence-based combination with prophetic medicine remedies. Journal of Hepatocellular Carcinoma, pp.1527-1546.
7- Assefa, M. and Biset, S., 2024. Prevalence of hepatitis B and C virus infections among visceral leishmaniasis patients: A systematic review and meta-analysis. Frontiers in Microbiology, 15, p.1415330.
8- Block, P.D., Shinn, B., Kim, J.H. and Hann, H.W., 2021. Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. Hepatic Oncology, 8(1), p.HEP35.
9- Alaridah, N., Joudeh, R.M., Al-Abdallat, H., Jarrar, R.A.F., Ismail, L., Jum’ah, M., Alnajjar, Z., Alzyoud, E., Battah, Z., Battah, A. and Alshami, M., 2023. Knowledge, attitude, and practices toward Hepatitis B infection among healthcare students—a nationwide cross-sectional study in Jordan. International Journal of Environmental Research and Public Health, 20(5), p.4348.
10- Bryant, J., Smith, A.K., Persson, A., Valentine, K., Drysdale, K., Wallace, J., Hamilton, M. and Newman, C.E., 2023. Logics of control and self-management in narratives of people living with HIV, hepatitis C and hepatitis B. Culture, Health & Sexuality, 25(9), pp.1214-1229.
11- Vimali, J., Yong, Y.K., Murugesan, A., Vishnupriya, K., Ashwin, R., Daniel, E.A., Balakrishnan, P., Raju, S., Rosmawati, M., Velu, V. and Larsson, M., 2022. Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control. Frontiers in medicine, 9, p.1019230.
12- Xia, Y., Cheng, X., Nilsson, T., Zhang, M., Zhao, G., Inuzuka, T., Teng, Y., Li, Y., Anderson, D.E., Holdorf, M. and Liang, T.J., 2023. Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome. Proceedings of the National Academy of Sciences, 120(49), p.e2306390120.
13- Zhang, X., Wang, X., Wu, M., Ghildyal, R. and Yuan, Z., 2021. Animal models for the study of hepatitis B virus pathobiology and immunity: past, present, and future. Frontiers in microbiology, 12, p.715450.
14- Zai, W., Hu, K., Ye, J., Ding, J., Huang, C., Li, Y., Fang, Z., Wu, M., Wang, C., Chen, J. and Yuan, Z., 2022. Long-term hepatitis B virus infection induces cytopathic effects in primary human hepatocytes, and can be partially reversed by antiviral therapy. Microbiology Spectrum, 10(1), pp.e01328-21.
15- Zorob, T., Farooqi, M.A., Ahsan, A., Zaki, A., Rathore, M.A. and Farooqi, H.M.U., 2023. Prevalence and Trends in Hepatitis B & C Virus among Blood Donors in Pakistan: A Regional Transfusion Center Study. Livers, 3(2), pp.271-281.